<unk>  is a muscarinic receptor antagonist that is FDA approved for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.   Common adverse reactions include constipation, Xerostomia.
Solifenacin
Proglumetacin
Revefenacin
Darifenacin
Arbekacin
Probenecid
Epoprostenol
Idebenone